Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy

Kyung-Yil Lee, Kyung-Yil Lee

Abstract

Acute respiratory distress syndrome (ARDS) is caused by infectious insults, such as pneumonia from various pathogens or related to other noninfectious events. Clinical and histopathologic characteristics are similar across severely affected patients, suggesting that a common mode of immune reaction may be involved in the immunopathogenesis of ARDS. There may be etiologic substances that have an affinity for respiratory cells and induce lung cell injury in cases of ARDS. These substances originate not only from pathogens, but also from injured host cells. At the molecular level, these substances have various sizes and biochemical characteristics, classifying them as protein substances and non-protein substances. Immune cells and immune proteins may recognize and act on these substances, including pathogenic proteins and peptides, depending upon the size and biochemical properties of the substances (this theory is known as the protein-homeostasis-system hypothesis). The severity or chronicity of ARDS depends on the amount of etiologic substances with corresponding immune reactions, the duration of the appearance of specific immune cells, or the repertoire of specific immune cells that control the substances. Therefore, treatment with early systemic immune modulators (corticosteroids and/or intravenous immunoglobulin) as soon as possible may reduce aberrant immune responses in the potential stage of ARDS.

Keywords: acute respiratory distress syndrome; corticosteroid; intravenous immunoglobulin; pathogenesis; pneumonia; protein-homeostasis-system.

Conflict of interest statement

The author declares no conflict of interest.

References

    1. Sharma S. Acute respiratory distress syndrome. BMJ. Clin. Evid. 2010;2010:1511.
    1. ARDS Definition Task Force. Ranieri V.M., Rubenfeld G.D., Thompson B.T., Ferguson N.D., Caldwell E., Fan E., Camporota L., Slutsky A.S. Acute respiratory distress syndrome: The Berlin Definition. JAMA. 2012;307:2526–2533.
    1. Dockrell D.H., Whyte M.K., Mitchell T.J. Pneumococcal pneumonia: Mechanisms of infection and resolution. Chest. 2012;142:482–491. doi: 10.1378/chest.12-0210.
    1. Van der Poll T., Opal S.M. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 2009;374:1543–1556. doi: 10.1016/S0140-6736(09)61114-4.
    1. Meunier I., Pillet S., Simonsen J.N., von Messling V. Influenza pathogenesis: Lessons learned from animal studies with H5N1, H1N1 Spanish, and pandemic H1N1 2009 influenza. Crit. Care. Med. 2010;38:e21–e29. doi: 10.1097/CCM.0b013e3181c8b4d5.
    1. Short K.R., Kroeze E.J., Fouchier R.A., Kuiken T. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect. Dis. 2014;14:57–69. doi: 10.1016/S1473-3099(13)70286-X.
    1. Cameron M.J., Bermejo-Martin J.F., Danesh A., Muller M.K., Kelvin D.J. Human immunopathogenesis of severe acute respiratory syndrome (SARS) Virus Res. 2008;133:13–19. doi: 10.1016/j.virusres.2007.02.014.
    1. Wang S.R., Tseng M.H., Lin W.J., Teng C.S., Wang C.C. Fatal non-typeable Haemophilus influenzae sepsis complicated with acute respiratory distress syndrome: Case report and literature review. Scand. J. Infect. Dis. 2005;37:921–925. doi: 10.1080/00365540500262492.
    1. Napolitano L.M., Brunsvold M.E., Reddy R.C., Hyzy R.C. Community-acquired methicillin-resistant Staphylococcus aureus pneumonia and ARDS: 1-year follow-up. Chest. 2009;136:1407–1412. doi: 10.1378/chest.07-1511.
    1. Belding M.E., Carbone J. Gonococcemia associated with adult respiratory distress syndrome. Rev. Infect. Dis. 1991;13:1105–1107. doi: 10.1093/clinids/13.6.1105.
    1. Ryu J.S., Cho J.H., Han H.S., Jung M.H., Yoon Y.H., Song E.S., Lee J.Y., Kim S.Y., Lee K.W., Kwak S.M., et al. Acute respiratory distress syndrome induced by adenovirus in an otherwise healthy woman. Yonsei Med. J. 2003;44:732–735. doi: 10.3349/ymj.2003.44.4.732.
    1. Dokos C., Masjosthusmann K., Rellensmann G., Werner C., Schuler L.S., Muller K.M., Schiborr M., Ehlert K., Groll A.H. Fatal human metapneumovirus infection following allogeneic hematopoietic stem cell. Transpl. Infect. Dis. 2013;15:97–101. doi: 10.1111/tid.12074.
    1. Gralinski L.E., Bankhead A., 3rd, Jeng S., Menachery V.D., Proll S., Belisle S.E., Matzke M., Webb-Robertson B.J., Luna M.L., Shukla A.K., et al. Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury. mBio. 2013 doi: 10.1128/mBio.00271-13.
    1. Piastra M., Onesimo R., De Luca D., Lancella L., Marzano L., De Rosa G., Pietrini D., Valentini P., Conti G. Measles-induced respiratory distress, air-leak and ARDS. Eur. J. Clin. Microbiol. Infect. Dis. 2010;29:81–85. doi: 10.1007/s10096-009-0838-x.
    1. Frangides C., Pneumatikos I. Varicella-zoster virus pneumonia in adults: Report of 14 cases and review of the literature. Eur. J. Intern. Med. 2004;15:364–370. doi: 10.1016/j.ejim.2004.04.016.
    1. Yano S. Acute respiratory distress syndrome due to chronic necrotizing pulmonary aspergillosis. Intern. Med. 2007;46:889–891. doi: 10.2169/internalmedicine.46.0016.
    1. Lahm T., Neese S., Thornburg A.T., Ober M.D., Sarosi G.A., Hage C.A. Corticosteroids for blastomycosis-induced ARDS: A report of two patients and review of the literature. Chest. 2008;133:1478–1480. doi: 10.1378/chest.07-2778.
    1. Burnik C., Altintas N.D., Ozkaya G., Serter T., Selçuk Z.T., Firat P., Arikan S., Cuenca-Estrella M., Topeli A. Acute respiratory distress syndrome due to Cryptococcus albidus pneumonia: Case report and review of the literature. Med. Mycol. 2007;45:469–473. doi: 10.1080/13693780701386015.
    1. Agarwal R., Gupta D., Handa A., Aggarwal A.N. Noninvasive ventilation in ARDS caused by Mycobacterium tuberculosis: Report of three cases and review of literature. Intensive Care Med. 2005;31:1723–1724. doi: 10.1007/s00134-005-2823-x.
    1. Van den Steen P.E., Deroost K., Deckers J., Van Herck E., Struyf S., Opdenakker G. Pathogenesis of malaria-associated acute respiratory distress syndrome. Trends Parasitol. 2013;29:346–358. doi: 10.1016/j.pt.2013.04.006.
    1. Baylor P., Larson R. Mycobacterium avium septicemia with ARDS in a patient with diabetes mellitus and no other known immune-compromising condition. J. Intensive Care Med. 2009;24:140–143. doi: 10.1177/0885066608330103.
    1. Horn K.A., Meyer W.T., Wyrick B.C., Zimmerman R.A. Group B streptococcal neonatal infection. JAMA. 1974;230:1165–1167. doi: 10.1001/jama.1974.03240080047029.
    1. Emre J.C., Baysak A., Oz A.T., Ece G., Arda B., Bacakoglu F. Vancomycin resistant enterococcus bacteremia in a patient with Pneumocystis jiroveci pneumonia, granulocystic sarcoma and acute respiratory distress syndrome. Pan Afr. Med. J. 2014;17:49. doi: 10.11604/pamj.2014.17.49.3246.
    1. Perl M., Lomas-Neira J., Venet F., Chung C.S., Ayala A. Pathogenesis of indirect (secondary) acute lung injury. Expert Rev. Respir. Med. 2011;5:115–126. doi: 10.1586/ers.10.92.
    1. Canet E., Osman D., Lambert J., Guitton C., Heng A.E., Argaud L., Klouche K., Mourad G., Legendre C., Timsit J.F., et al. Acute respiratory failure in kidney transplant recipients: A multicenter study. Crit. Care. 2011;15:R91. doi: 10.1186/cc10091.
    1. Putzke C., Max M., Geldner G., Wulf H. Severe ARDS following perioperative aspiration of gastric content associated with the use of a “ProSeal” laryngeal mask airway. Anasthesiol. Intensivmed. Notfallmed. Schmerzther. 2005;40:487–489. doi: 10.1055/s-2004-826198.
    1. Gregorakos L., Markou N., Psalida V., Kanakaki M., Alexopoulou A., Sotiriou E., Damianos A., Myrianthefs P. Near-drowning: Clinical course of lung injury in adults. Lung. 2009;187:93–97. doi: 10.1007/s00408-008-9132-4.
    1. Michalska A., Jurczyk A.P., Machała W., Szram S., Berent J. Pulmonary contusion and acute respiratory distress syndrome (ARDS) as complications of blunt chest trauma. Arch. Med. Sadowej Kryminol. 2009;59:148–154.
    1. Calfee C.S., Matthay M.A., Eisner M.D., Benowitz N., Call M., Pittet J.F., Cohen M.J. Active and passive cigarette smoking and acute lung injury after severe blunt trauma. Am. J. Respir. Crit. Care Med. 2011;183:1660–1665. doi: 10.1164/rccm.201011-1802OC.
    1. Bordes J., Lacroix G., Esnault P., Goutorbe P., Cotte J., Dantzer E., Meaudre E. Comparison of the Berlin definition with the American European Consensus definition for acute respiratory syndrome in burn patients. Burns. 2014;40:562–567. doi: 10.1016/j.burns.2014.03.004.
    1. Rodríguez-Moyado H. Acute lung injury as a consequence of blood transfusion. Rev. Med. Inst. Mex. Seguro Soc. 2011;49:273–280.
    1. Kelly C.A., Upex A., Spencer E.P., Flanagan R.J., Bateman D.N. Adult respiratory distress syndrome and renal failure associated with citalopram overdose. Hum. Exp. Toxicol. 2003;22:103–105. doi: 10.1191/0960327103ht327cr.
    1. Elder A.S., Saccone G.T., Dixon D.L. Lung injury in acute pancreatitis: Mechanisms underlying augmented secondary injury. Pancreatology. 2012;12:49–56. doi: 10.1016/j.pan.2011.12.012.
    1. Dong L.Y., Zheng J.H., Qiu X.X., Yu M., Ye Y.Z., Shi S., Yang D.C., Xie Y.W. Ischemic preconditioning reduces deep hypothermic circulatory arrest cardiopulmonary bypass induced lung injury. Eur. Rev. Med. Pharmacol. Sci. 2013;17:1789–1799.
    1. Hendrickson C.M., Howard B.M., Kornblith L.Z., Conroy A.S., Nelson M.F., Zhuo H., Liu K.D., Manley G.T., Matthay M.A., Calfee C.S., et al. The acute respiratory distress syndrome following isolated severe traumatic brain injury. J. Trauma Acute Care Surg. 2016;80:989–997. doi: 10.1097/TA.0000000000000982.
    1. Beutler B.A. TLRs and innate immunity. Blood. 2009;113:1399–1407. doi: 10.1182/blood-2008-07-019307.
    1. Matzinger P. The danger model: A renewed sense of self. Science. 2002;296:301–305. doi: 10.1126/science.1071059.
    1. Vénéreau E., Ceriotti C., Bianchi M.E. DAMPs from cell death to new life. Front. Immunol. 2015;6:422. doi: 10.3389/fimmu.2015.00422.
    1. Lee K.Y., Rhim J.W., Kang J.H. Hyperactive immune cells (T cells) may be responsible for acute lung injury in influenza virus infections: A need for early immune-modulators for severe cases. Med. Hypotheses. 2011;76:64–69. doi: 10.1016/j.mehy.2010.08.032.
    1. Lee K.Y., Rhim J.W., Kang J.H. Kawasaki disease: Laboratory findings and an immunopathogenesis on the premise of a “protein homeostasis system”. Yonsei Med. J. 2012;53:262–275. doi: 10.3349/ymj.2012.53.2.262.
    1. Lee K.Y. A common immunopathogenesis mechanism for infectious diseases: The protein-homeostasis-system hypothesis. Infect. Chemother. 2015;47:12–26. doi: 10.3947/ic.2015.47.1.12.
    1. Rhim J.W., Go E.J., Lee K.Y., Youn Y.S., Kim M.S., Park S.H., Kim C.C., Kang J.H. Pandemic 2009 H1N1 virus infection in children and adults: A cohort study at a single hospital throughout the epidemic. Int. Arch. Med. 2012;5:13. doi: 10.1186/1755-7682-5-13.
    1. Shanks G.D., Lee S.E., Howard A., Brundage J.F. Extreme mortality after first introduction of measles virus to the Polynesian island of Rotuma, 1911. Am. J. Epidemol. 2011;173:1211–1222. doi: 10.1093/aje/kwq504.
    1. Nakajima N., Sato Y., Katano H., Hasegawa H., Kumasaka T., Hata S., Tanaka S., Amano T., Kasai T., Chong J.M., et al. Histopathological and immunohistochemical findings of 20 autopsy cases with 2009 H1N1 virus infection. Mod. Pathol. 2012;25:1–13. doi: 10.1038/modpathol.2011.125.
    1. Zhang Y., Sun H., Fan L., Ma Y., Sun Y., Pu J., Yang J., Qiao J., Ma G., Liu J. Acute respiratory distress syndrome induced by a swine 2009 H1N1 variant in mice. PLoS ONE. 2012;7:e29347. doi: 10.1371/journal.pone.0029347.
    1. Lee K.Y. Pediatric respiratory infections by Mycoplasma pneumoniae. Expert Rev. Anti-Infect. Ther. 2008;6:509–521. doi: 10.1586/14787210.6.4.509.
    1. Bhatt N.Y., Allen J.N. Update on eosinophilic lung diseases. Semin. Respir. Crit. Care Med. 2012;33:555–571.
    1. Wyatt R.J., Julian B.A. IgA nephropathy. N. Engl. J. Med. 2013;368:2402–2414. doi: 10.1056/NEJMra1206793.
    1. Hers J.F., Goslings W.R., Masurel N., Mulder J. Death from Asiatic influenza in the Netherlands. Lancet. 1957;273:1164–1165. doi: 10.1016/S0140-6736(57)92066-4.
    1. Sheu C.C., Gong M.N., Zhai R., Chen F., Bajwa E.K., Clardy P.F., Gallagher D.C., Thompson B.T., Christiani D.C. Clinical characteristics and outcomes of sepsis-related vs. non-sepsis-related ARDS. Chest. 2010;138:559–567. doi: 10.1378/chest.09-2933.
    1. Denny F.W., Taylor-Robinson D., Allison A.C. The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice. J. Med. Microbiol. 1972;5:327–336. doi: 10.1099/00222615-5-3-327.
    1. Tanaka H., Honma S., Abe S., Tamura H. Effects of IL-2 and cyclosporin A on pathologic features in mycoplasma pneumonia. Am. J. Respir. Crit. Care Med. 1996;154:1908–1912. doi: 10.1164/ajrccm.154.6.8970385.
    1. Wyde R.R., Couch R.B., Mackler B.F., Cate T.R., Levy B.M. Effects of low- and high-passage influenza virus infection in normal and nude mice. Infect. Immun. 1997;15:221–229.
    1. Crowe C.R., Chen K., Pociask D.A., Alcorn J.F., Krivich C., Enelow R.I., Ross T.M., Witztum J.L., Kolls J.K. Critical role of IL-17RA in immunopathology of influenza infection. J. Immunol. 2009;183:5301–5310. doi: 10.4049/jimmunol.0900995.
    1. Denny F.W., Clyde W.A., Jr., Glezen W.P. Mycoplasma pneumoniae disease: Clinical spectrum, pathophysiology, epidemiology, and control. J. Infect. Dis. 1971;123:74–92. doi: 10.1093/infdis/123.1.74.
    1. Yasui S., Fujiwara K., Yonemitsu Y., Oda S., Nakano M., Yokosuka O. Clinicopathological features of severe and fulminant forms of autoimmune hepatitis. J. Gastroenterol. 2011;46:378–390. doi: 10.1007/s00535-010-0316-3.
    1. Poletti V., Romagnoli M., Piciucchi S., Chilosi M. Current status of idiopathic nonspecific interstitial pneumonia. Semin. Respir. Crit. Care Med. 2012;33:440–449.
    1. Sagar S., Liu P.P., Cooper L.T., Jr. Myocarditis. Lancet. 2012;379:738–747. doi: 10.1016/S0140-6736(11)60648-X.
    1. Lahmer T., Heemann U. Anti-glomerular basement membrane antibody disease: A rare autoimmune disorder affecting the kidney and the lung. Autoimmun. Rev. 2012;12:169–173. doi: 10.1016/j.autrev.2012.04.002.
    1. Talukdar R., Swaroop-Vege S. Early management of severe acute pancreatitis. Curr. Gastroenterol. Rep. 2011;13:123–130. doi: 10.1007/s11894-010-0174-4.
    1. Hoshino A., Saitoh M., Oka A., Okumura A., Kubota M., Saito Y., Takanashi J., Hirose S., Yamagata T., Yamanouchi H., et al. Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes. Brain Dev. 2012;34:337–343. doi: 10.1016/j.braindev.2011.07.012.
    1. Hamilton D., Harris M.D., Foweraker J., Gresham G.A. Waterhouse-Friderichsen syndrome as a result of non-meningococcal infection. J. Clin. Pathol. 2004;57:208–209. doi: 10.1136/jcp.2003.9936.
    1. Downey A., Jackson C., Harun N., Cooper A. Toxic epidermal necrolysis: Review of pathogenesis and management. J. Am. Acad. Dermatol. 2012;66:995–1003. doi: 10.1016/j.jaad.2011.09.029.
    1. Ranjit S., Kissoon N. Dengue hemorrhagic fever and shock syndromes. Pediatr. Crit. Care Med. 2011;12:90–100. doi: 10.1097/PCC.0b013e3181e911a7.
    1. Chaithanyaa N., Devireddy S.K., Kishore-Kumar R.V., Gali R.S., Aneja V. Sympathetic ophthalmia: A review of literature. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2012;113:172–176. doi: 10.1016/j.tripleo.2011.01.036.
    1. Hung P.L., Lin P.C., Tseng P.L. Influenza-B associated rhabdomyolysis and acute renal failure. Indian Pediatr. 2013;50:595–596. doi: 10.1007/s13312-013-0158-1.
    1. Seibold S., Merkel F., Weber M., Marx M. Rhabdomyolysis and acute renal failure in an adult with measles virus infection. Nephrol. Dial. Transplant. 1998;13:1829–1831. doi: 10.1093/ndt/13.7.1829.
    1. Khan F.Y. Rhabdomyolysis: A review of the literature. Neth. J. Med. 2009;67:272–283.
    1. Narasaraju T., Yang E., Samy R.P., Ng H.H., Poh W.P., Liew A.A. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am. J. Pathol. 2011;179:199–210. doi: 10.1016/j.ajpath.2011.03.013.
    1. Yousefi S., Simon D., Simon H.U. Eosinophil extracellular DNA traps: Molecular mechanisms and potential roles in disease. Curr. Opin. Immunol. 2012;24:736–739. doi: 10.1016/j.coi.2012.08.010.
    1. Wang H., Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am. J. Emerg. Med. 2008;26:711–715. doi: 10.1016/j.ajem.2007.10.031.
    1. Becker A., Kannan T.T., Taylor A.B., Pakhomova O.N., Zhang Y., Somarajan S.R., Galaleldeen A., Holloway S.P., Baseman J.B., Hart P.J. Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae. Proc. Natl. Acad. Sci. USA. 2015;112:5165–5170. doi: 10.1073/pnas.1420308112.
    1. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011;34:637–650. doi: 10.1016/j.immuni.2011.05.006.
    1. Kumar S., Ingle H., Prasad D.V., Kumar H. Recognition of bacterial infection by innate immune sensors. Crit. Rev. Microbiol. 2013;39:229–246. doi: 10.3109/1040841X.2012.706249.
    1. Khasbiullina N.R., Bovin N.V. Hypotheses of the origin of natural antibodies: A glycobiologist’s opinion. Biochemistry (Mosc.) 2015;80:820–835. doi: 10.1134/S0006297915070032.
    1. UNICEF and WHO Pneumonia: The Forgotten Killer of Children. 2006. [(accessed on 31 October 2016)]. Available online: .
    1. Lassi Z.S., Kumar R., Das J.K., Salam R.A., Bhutta Z.A. Antibiotic therapy versus no antibiotic therapy for children aged two to 59 months with WHO-defined non-severe pneumonia and wheeze. Cochrane Database Syst. Rev. 2014;26:CD009576.
    1. Garcia-Vidal C., Carratalà J. Early and late treatment failure in community-acquired pneumonia. Semin. Respir. Crit. Care Med. 2009;30:154–160. doi: 10.1055/s-0029-1202934.
    1. Menéndez R., Torres A., Zalacaín R., Aspa J., Martín-Villasclaras J.J., Borderías L., Benítez-Moya J.M., Ruiz-Manzano J., Rodríguez de Castro F., Blanquer J., et al. Neumofail Group. Risk factors of treatment failure in community acquired pneumonia: Implications for disease outcome. Thorax. 2004;59:960–965. doi: 10.1136/thx.2003.017756.
    1. Youn Y.S., Lee K.Y. Mycoplasma pneumoniae pneumonia in children. Korean J. Pediatr. 2012;55:42–47. doi: 10.3345/kjp.2012.55.2.42.
    1. Tsai Y.F., Ku Y.H. Necrotizing pneumonia: A rare complication of pneumonia requiring special consideration. Curr. Opin. Pulm. Med. 2012;18:246–252. doi: 10.1097/MCP.0b013e3283521022.
    1. Jefferson T., Doshi P. Multisystem failure: The story of anti-influenza drugs. BMJ. 2014;348:g2263. doi: 10.1136/bmj.g2263.
    1. Rhim J.W., Lee K.Y., Youn Y.S., Kang J.H., Kim J.C. Epidemiological and clinical characteristics of childhood pandemic 2009 H1N1 virus infection: An observational cohort study. BMC Infect. Dis. 2011;11:225. doi: 10.1186/1471-2334-11-225.
    1. Marti C., Grosgurin O., Harbarth S., Combescure C., Abbas M., Rutschmann O., Perrier A., Garin N. Adjunctive corticotherapy for community acquired pneumonia: A systematic review and meta-analysis. PLoS ONE. 2015;10:e0144032. doi: 10.1371/journal.pone.0144032.
    1. Ruan S.Y., Lin H.H., Huang C.Y.T., Kuo P.H., Wu H.D., Yu C.J. Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: A systematic review and meta-analysis. Crit. Care. 2014;18:R63. doi: 10.1186/cc13819.
    1. Annane D. Pro: The illegitimate crusade against corticosteroids for severe H1N1 pneumonia. Am. J. Respir. Crit. Care Med. 2011;183:1125–1126. doi: 10.1164/rccm.201102-0345ED.
    1. Matthay M.A., Lia K.D. Con: Corticosteroids are not indicated for treatment of acute lung injury from H1N1 viral pneumonia. Am. Respir. Crit. Care Med. 2011;183:1127–1128. doi: 10.1164/rccm.201103-0395ED.
    1. Blum C.A., Nigro N., Briel M., Schuetz P., Ullmer E., Suter-Widmer I., Winzeler B., Bingisser R., Elsaesser H., Drozdov D., et al. Adjunct prednisone therapy for patients with community-acquired pneumonia: A multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2015;385:1511–1518. doi: 10.1016/S0140-6736(14)62447-8.
    1. Torres A., Sibila O., Ferrer M., Polverino E., Menendez R., Mensa J., Gabarrús J., Sellarés J., Restrepo M.I., Anzueto A., et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial. JAMA. 2015;313:677–686. doi: 10.1001/jama.2015.88.
    1. Kil H.R., Lee J.H., Lee K.Y., Rhim J.W., Youn Y.S., Kang J.H. Early corticoid treatment for severe pneumonia caused by 2009 H1N1 influenza virus. Crit. Care. 2011;15:413. doi: 10.1186/cc10082.
    1. Lee K.Y., Lee H.S., Hong J.H., Lee M.H., Lee J.S., Burgner D., Lee B.C. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatr. Pulmonol. 2006;41:263–268. doi: 10.1002/ppul.20374.
    1. Youn Y.S., Lee S.C., Rhim J.W., Shin M.S., Kang J.H., Lee K.Y. Early additional immune-modulators for Mycoplasma pneumoniae pneumonia in children: An observation study. Infect. Chemother. 2014;46:239–247. doi: 10.3947/ic.2014.46.4.239.
    1. Fernandes R.M., Bialy L.M., Vandermeer B., Tjosvold L., Plint A.C., Patel H., Johnson D.W., Klassen T.P., Hartling L. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst. Rev. 2013;6:CD004878.
    1. Lee K.Y., Hwang J.Y., Rhim J.W., Kang J.H., Lee J.S., Kim J.C. Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia. BMC Pediatr. 2010;10:48.
    1. Wang L., Chang L.S., Lee I.K., Tang K.S., Li C.C., Eng H.L., You H.L., Yang K.D. Clinical diagnosis of pandemic A (H1N1) 2009 influenza in children with negative rapid influenza diagnostic test by lymphopenia and lower C-reactive protein levels. Influenza Other Respir. Viruses. 2014;8:91–98. doi: 10.1111/irv.12182.
    1. Lee K.Y., Lee H.S., Hur J.K., Kang J.H., Lee B.C. Clinical features of measles according to age in a measles epidemic. Scand. J. Infect. Dis. 2005;37:471–475. doi: 10.1080/00365540510037803.
    1. Chen C.Y., Lee C.H., Liu C.Y., Wang J.H., Wang L.M., Perng R.P. Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome. J. Chin. Med. Assoc. 2005;68:4–10. doi: 10.1016/S1726-4901(09)70124-8.
    1. Tumpey T.M., Lu X., Morken T., Zaki S.R., Katz J.M. Depletion of lymphocytes and diminished cytokine production in mice with a highly virulent influenza A (H5N1) virus isolated from humans. J. Virol. 2000;74:6105–6116. doi: 10.1128/JVI.74.13.6105-6116.2000.
    1. Olnes M.J., Kotliarov Y., Biancotto A., Cheung F., Chen J., Shi R., Zhou H., Wang E., Tsang J.S., Nussenblatt R. CHI Consortium. Effects of systemically administered hydrocortisone on the human immunome. Sci. Rep. 2016;6:23002. doi: 10.1038/srep23002.
    1. Burns J.C., Franco A. The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease. Expert Rev. Clin. Immunol. 2015;11:819–825. doi: 10.1586/1744666X.2015.1044980.
    1. Brower R.G., Lanken P.N., MacIntyre N., Matthay M.A., Morris A., Ancukiewicz M., Schoenfeld D., Thompson B.T. National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N. Engl. J. Med. 2004;351:327–336.
    1. Amato M.B., Meade M.O., Slutsky A.S., Brochard L., Costa E.L., Schoenfeld D.A., Stewart T.E., Briel M., Talmor D., Mercat A., et al. Driving pressure and survival in the acute respiratory distress syndrome. N. Engl. J. Med. 2015;372:747–755. doi: 10.1056/NEJMsa1410639.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner